Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ba253BINEB vs MDI in COPD
NCT02182583Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 1998
- Primary completion
- Jun 2000
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of oxitropium bromide in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Oct 1998; status: completed.
02
Drugs
oxitropium bromide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02182583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182583.